Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Fellowship, Child and Adolescent Psychiatry, 1996
    Children's National Medical Center
  • Fellowship, 1994
    Warren Magnuson Clinical Center/National Institute of Health
  • Residency, Psychiatry, 1991
    National Institute of Health
  • Residency, Psychiatry, 1990
    Johns Hopkins Hospital
  • Internship, Internal Medicine, 1988
    Johns Hopkins Geriatric Center
  • MD, 1987
    Johns Hopkins University School of Medicine

Board Certifications

  • American Board of Psychiatry & Neurology-Psychiatry
  • American Board of Psychiatry & Neurology-Child & Adolescent

Awards & Recognition

  • Top Doctors Washingtonian (2022, 2021, 2019)
  • Top Doctors No Va Magazine (2023, 2022, 2021)

National Provider ID: 1033209309


Adelaide Robb, M.D., is a psychopharmacologist with ongoing research studies in depression and mood disorders, anxiety and attention deficit disorder. She is Chief of the Division of Psychiatry and Behavioral Sciences. 

Dr. Robb, who trained at Johns Hopkins University and the National Institutes of Health, has been on the medical staff in the Division of Psychiatry and Behavioral Medicine since 1996, rising to the rank of Professor (with tenure). She is an internationally known clinical researcher and has participated in and led multiple therapeutic trials for children with a variety of behavioral and psychiatric conditions. 

Patients interested in participating in research studies are seen at Children's National Hospital on Michigan Avenue in Northwest Washington, D.C. Patients who want a second opinion in psychopharmacologic management can be seen at the Fairfax office.

For more information about Psychopharmacology trials at Children’s National, please visit the Psychiatry Clinical Trials page or contact Dr. Robb’s team at 202-476-6067.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • American Academy of Child and Adolescent Psychiatry
  • American Academy of Pediatrics
  • Child and Adolescent Society of Greater Washington
  • Covance
  • Eli Lilly
  • Pfizer
  • Takada
  • Supernus
  • Bracket

Research & Publications

A Dose Response Study of Concerta Methylphenidate in Children with Attention Deficit Hyperactivity Disorder

(2003) Pediatrics

A Randomized, Placebo-Controlled Trial of Citalopram for the Treatment of Major Depression in Children and Adolescents(2004) The American Journal of Psychiatry

Case Study Can Stimulant Rebound Mimic Pediatric Bipolar Disorder

(2002) Journal of Child and Adolescent Psychopharmacology

Dopamine Transporter Genotype and Methylphenidate Dose Response in Children with ADHD

(2005) Neuropsychopharmacology

Eating Disorders in Males

(2002) Child and Adolescent Psychiatric Clinics of North America

Master of Disguise Eating Disorders in the Emergency Room

(2004) Pediatric Emergency Medicine

Neural Circuitry Engaged During Unsuccessful Motor Inhibition in Pediatric Bipolar Disorder vs Controls

(2007) American Journal of Psychiatry

Nocturnal Nasogastric Refeeding for Hospitalized Adolescent Boys with Anorexia Nervosa

(2004) Developmental and Behavioral Pediatrics

Supplemental Nocturnal Nasogastric Refeeding may Improve Short-term Outcome in Inpatient Adolescent Females with Anorexia Nervosa

(2002) The American Journal of Psychiatry

Treatment of ADHD A Developmental Approach

(2007) Consultant for Pediatricians